Medical University of South Carolina Sep 2 2025 Researchers at MUSC Hollings Cancer Center have discovered a potentially powerful weapon in the fight against head and neck cancers. The new drug, still in preclinical studies, attacks cancer cells from within by damaging their mitochondria, the cells' energy factories. The study, published in Cancer Research , was led by Besim Ogretmen, Ph.D., associate director of Basic Science at Hollings and director of Hollings' Lipidomics Shared Resource.